|
 |
|
| Figure 1. Lipoprotein structure. |
Figure 2. Spectrum of plasma
lipoprotein particles. |
| |
|
|
 |
| Figure 3. Metabolism of chylomicrons, VLDL,
IDL and LDL. |
Figure 4. Relationship between serum cholesterol
and the incidence of CHD. |
| |
|
|
|
| Figure 5. Risk of myocardial infarction
over six years. |
Table 1. The Fredrickson/WHO classification
of hyperlipoproteinaemia |
| |
|
|
|
| Figure 6. Types of xanthoma in familial
hypercholesterolaemia. |
Table 2. Estimates of UK mortality from
CHD in men. |
| |
|
|
|
| Figure 7. Age-adjusted death
from CHD. |
Figure 8a. CHD risk prediction charts: no
diabetes. |
| |
|
|
|
|
|
| Figure 8b. CHD risk prediction charts: diabetes. |
|
Figure 9. Xanthoma in type III hyperlipoproteinaemia. |
| |
|
|
|
|
|
| Figure 10. Manifestations of severe hypertriglyceridaemia. |
|
Table 3. Common causes of secondary hyperlipoproteinaemia. |
| |
|
|
| |
|
|